logo

For the Inventor, By the Inventor

Plymouth Meeting, PA, United States of America

Genaera Corporation


USPTO Granted Patents = 21

% Expired Patents = 66.7



Forward Citations = 157

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Nicholas C Nicolaides (16 out of 88 patents)

silverMedal Roy Clifford Levitt (16 out of 23 patents)

bronzeMedal Kenneth J Holroyd (8 out of 8 patents)

4.  W Lee Maloy (7 out of 18 patents)

5.  Yuhong Zhou (6 out of 16 patents)

6.  Mike McLane (6 out of 6 patents)

7.  Luigi Grasso (5 out of 72 patents)

8.  William Alvin Kinney (5 out of 65 patents)

9.  U Prasad Kari (4 out of 4 patents)

10.  Steve Jones (4 out of 4 patents)

11.  Michael A Zasloff (4 out of 56 patents)

12.  Jamila Louahed (3 out of 4 patents)

13.  Qu Dong (3 out of 3 patents)

14.  Jon I Williams (2 out of 15 patents)

15.  Michael McLane (1 out of 12 patents)


21 patents:

1. 7704710 - Interleukin-9 receptor mutants (2010-04-27),
2. 7700088 - Interleukin-9 mutein peptides (2010-04-20),
3. 7504409 - Mucin synthesis inhibitors (2009-03-17),
4. 7410959 - Therapeutic uses for aminosterol compounds (2008-08-12),
5. 7384767 - Nucleic acid encoding an interleukin-9 receptor variant (2008-06-10),
6. 7345051 - Mucin synthesis inhibitors (2008-03-18),
7. 7211254 - Methods for treating ICACC protein associated diseases (2007-05-01),
8. 7208292 - Nucleic acid encoding an interleukin-9 receptor variant (2007-04-24),
9. 7192578 - Interleukin-9 mutein peptides (2007-03-20),
10. 7074778 - Asthma associated factors as targets for treating atopic allergies including asthma and related disorders (2006-07-11),
11. 7056698 - Nucleic acids encoding interleukin-9 receptor variants (2006-06-06),
12. 6962909 - Treatment of neovascularization disorders with squalimine (2005-11-08),
13. 6933383 - Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols (2005-08-23),
14. 6737427 - Mucin synthesis inhibitors (2004-05-18),
15. 6716603 - Nucleic acids encoding a chloride channel protein (2004-04-06),
Company Overview
Genaera Corporation is a biopharmaceutical company based in Plymouth Meeting, Pennsylvania, specializing in the development of innovative therapies for serious medical conditions. The company focuses on research in areas such as oncology and metabolic diseases, leveraging advanced scientific methodologies to create effective treatment options. Genaera's commitment to addressing unmet medical needs drives its research initiatives, aiming to improve patient outcomes through targeted therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

21 Patents

#5 in Plymouth Meeting, PA

#571 in Pennsylvania

#15,695 in US

#29,961 in the World

Plymouth Meeting, PA (US)
Plymouth Meeting, PA, United States of America

Genaera Corporation

Forward Citations = 157

24 inventors:

goldMedal Nicholas C Nicolaides (16 out of 88 patents)

silverMedal Roy Clifford Levitt (16 out of 23 patents)

bronzeMedal Kenneth J Holroyd (8 out of 8 patents)

4.  W Lee Maloy (7 out of 18 patents)

5.  Yuhong Zhou (6 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genaera Corporation. Retrieved from https://idiyas.com/company/genaera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…